OverviewSuggest Edit

Regenicin, Inc. is a biotechnology company specializing in the development of regenerative cell therapies to restore the health of damaged tissues and organs. Regenicin has assembled a world class management team with a proven track record for developing and bringing innovative medical devices and biotechnology products to market. Regenicin is working to bring the product candidate, Regenicin cultured skin substitute, to market. Regenicin cultured skin substitute is an exciting breakthrough technology that uses the patient’s own skin cells to generate living, tissue-engineered skin for the treatment of chronic burns and wounds. 

TypePublic
Founded2010
HQLittle Falls, US
Websiteregenicin.com

Locations

Regenicin is headquartered in
Little Falls, United States

Location Map

Latest Updates

Employees (est.) (Feb 2019)3(-25%)

Regenicin Office Locations

Regenicin has an office in Little Falls
Little Falls, US (HQ)
10 High Ct
Show all (1)

Regenicin Financials and Metrics

Regenicin Revenue

USD

Net income (Q2, 2019)

(178.4k)

EBIT (Q2, 2019)

(176.2k)

Market capitalization (8-Oct-2018)

5.2m

Cash (31-Mar-2019)

1.6k
Regenicin's current market capitalization is $5.2 m.
Annual
USDFY, 2013FY, 2015FY, 2016FY, 2017FY, 2018

General and administrative expense

917.8k1.1m1.1m970.8k789.1k

R&D expense

80.0k38.4k1.4k5.3k

Operating expense total

4.0m241.8k1.2m976.1k789.1k

EBIT

(4.0m)(241.8k)(779.9k)(961.1k)(540.3k)
Quarterly
Annual
USDFY, 2013FY, 2015FY, 2016FY, 2017FY, 2018

Cash

22.5k1.1m218.8k19.2k2.7k

Current Assets

88.8k1.5m292.6k87.8k

Total Assets

96.3k1.5m359.8k87.8k

Accounts Payable

1.4m360.2k262.9k281.0k67.5k
Quarterly
USDQ2, 2014Q3, 2014Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q2, 2018Q3, 2018Q1, 2019Q2, 2019

Cash

3.2k360.01.4m794.8k586.1k343.4k50.4k40.1k12.0k2.1k1.3k1.8k1.6k

Current Assets

33.4k12.4k3.1m403.6k184.5k167.9k57.1k37.9k

Total Assets

40.9k19.9k3.1m468.2k184.5k167.9k57.1k37.9k

Accounts Payable

1.5m1.4m379.4k346.4k378.7k338.6k264.9k264.9k270.4k296.4k296.4k67.5k67.6k
Annual
USDFY, 2013FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

(4.9m)242.6k(1.1m)973.9k(559.1k)

Accounts Payable

31.1k(380.3k)318.8k33.0k35.4k

Cash From Operating Activities

(685.1k)(2.0m)(693.3k)(311.7k)(133.7k)

Cash From Investing Activities

3.6m(67.3k)
Quarterly
USDQ2, 2014Q3, 2014Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q2, 2018Q3, 2018Q1, 2019Q2, 2019

Net Income

(390.8k)(699.6k)3.3m(364.2k)(657.7k)(967.5k)281.8k580.2k779.0k(441.4k)(627.8k)247.3k(425.7k)

Accounts Payable

119.5k5.5k(361.1k)(13.8k)18.5k(21.6k)16.9k17.0k22.5k15.4k15.4k(2.0)45.0

Cash From Operating Activities

(118.8k)(168.5k)(1.6m)(266.5k)(460.2k)(595.6k)(155.4k)(161.6k)(251.1k)(80.5k)(84.2k)(101.5k)(103.1k)

Cash From Investing Activities

3.6m57.3k
Show all financial metrics

Regenicin Frequently Asked Questions

  • When was Regenicin founded?

    Regenicin was founded in 2010.

  • How many employees does Regenicin have?

    Regenicin has 3 employees.

  • Who are Regenicin competitors?

    Competitors of Regenicin include Interface Biologics, CEL-SCI and Pfenex.

  • Where is Regenicin headquarters?

    Regenicin headquarters is located at 10 High Ct, Little Falls.

  • Where are Regenicin offices?

    Regenicin has an office in Little Falls.

  • How many offices does Regenicin have?

    Regenicin has 1 office.